Browse > Article

Expression of NGF in Estradiol Valerate-Induced Polycystic Ovary and CHO Cells  

Choi, Baik-Dong (Department of Oral Histology and Developmental Biology, School of Dentistry, Chosun University)
Jeong, Soon-Jeong (Department of Oral Histology and Developmental Biology, School of Dentistry, Chosun University)
Jeong, Moon-Jin (Department of Oral Histology and Developmental Biology, School of Dentistry, Chosun University)
Lim, Do-Seon (Department of Dental Hygiene, Eulji University)
Lee, Soo-Han (College of Veterinary Medicine, Konkuk University)
Kim, Seung-Hyun (College of Veterinary Medicine, Chonnam National University)
Go, A-Ra (College of Veterinary Medicine, Chonnam National University)
Kim, Se-Eun (College of Veterinary Medicine, Chonnam National University)
Kang, Seong-Soo (College of Veterinary Medicine, Chonnam National University)
Bae, Chun-Sik (College of Veterinary Medicine, Chonnam National University)
Publication Information
Applied Microscopy / v.41, no.2, 2011 , pp. 109-116 More about this Journal
Abstract
Polycystic ovary syndrome (PCOS) is hormonal imbalance condition as the endocrine and metabolic disorder that induces the infertility and various complications in reproductive age women. Estradiol valerate (EV) is used hormone replacement therapy in menopausal women and is reported that excessive administration of EV induces the PCOS. Nerve growth factor (NGF) is the factor to regulate the survival and maturation of developing neuronal cell and is also synthesized in ovary. And NGF is overexpressed in EV-induced polycystic ovary (PCO) as previously reported. Therefore, this study examined the possibility of NGF as can be used the biological marker in diagnosis of PCOS, the hormonal imbalance condition, using PCO and CHO (chinese hamster ovarian) cell lines. The concentration of EV treatment is optimized a 1 mg as not influence on the proliferation of CHO cell but 2 mg and 3 mg of EV treatment have the inhibition effect at initial stage. The morphological change was not observed in CHO cell after dose dependent manner treatment of EV. Expression of NGF mRNA and protein is significantly increased at 30 min after EV treatment in CHO cells compared to that of control. And NGF protein expression is strongly increased in PCO tissue, which observed many follicular cysts compared to normal ovary tissue. Taken together, overexpression of NGF may be act as a molecule to induce an abnormal development of follicle, suggesting that NGF can be used as a biological marker in diagnosis of PCOS.
Keywords
CHO cell; Estradiol Valerate; NGF; PCO; Rat;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Balen AH: The pathogenesis of polycystic ovary syndrome: the enigma unravels. Lancet 354 : 966-967, 1999.   DOI   ScienceOn
2 Barria A, Leyton V, Ojeda SR, Lara HE: Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation. Endocrinology 133 : 2696-2703, 1993.   DOI   ScienceOn
3 Conner P, Register TC, Skoog L, Tani E, von Schoultz B, Cline JM: Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys. Am J Obstet Gynecol 193(1) : 58-63, 2005.   DOI   ScienceOn
4 Amato G, Conte M, Mazziotti G, Lalli E, Vitolo G, Tucker AT, Bellastella A, Carella C, Izzo A: Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol 101 : 1177-1182, 2003.   DOI   ScienceOn
5 Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE: Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82 : 2248-2256, 1997.   DOI   ScienceOn
6 Artini PG, Monteleone P, Toldin MRP, Matteucci C, Ruggiero M, Cela V, Genazzani AR: Growth factors and folliculogenesis in polycystic ovary patients. Expert Rev Endocrinol Metab 2 : 215-223, 2007.   DOI
7 Zhuang YH, Sarca D, Weisz A, Altucci L, Cicatiello L, Rollerova E, Tuohimaa P, Ylikomi T: Cell type-specific induction of cyclin D and cyclin-dependent kinase inhibitor p27(kip1) expression by estrogen in rat endometrium. J Steroid Biochem Mol Biol 78(2) : 193-199, 2001.   DOI   ScienceOn
8 Stener-Victorin E, Lundeberg T, Cajander S, Aloe L, Manni L, Waldenstrom U, Janson PO: Steroid-induced polycystic ovaries in rats: effect of electro-acupuncture on concentrations of endothelin- 1 and nerve growth factor (NGF), and expression of NGF mRNA in the ovaries, the adrenal glands, and the central nervous system. Reprod Biol Endocrinol 1 : 33-40, 2003.   DOI
9 Taishi P, Churchill L, De A, Obal F Jr, Krueger JM: Cytokine mRNA induction by interleukin-1beta or tumor necrosis factor alpha in vitro and in vivo. Brain Res 1226 : 89-98, 2008.
10 Takaoka K, Shirai Y, Saito N: Inflammatory cytokine tumor necrosis factor-alpha enhances nerve growth factor production in human keratinocytes, HaCaT cells. J Pharmacol Sci 111(4) : 381-391, 2009.   DOI   ScienceOn
11 Tokusashi Y, Asai K, Tamakawa S, Yamamoto M, Yoshie M, Yaginuma Y, Miyokawa N, Aoki T, Kino S, Kasai S, Ogawa K: Expression of NGF in hepatocellular carcinoma cells with its receptors in non-tumor cell components. Int J Cancer 114 : 39-45, 2005.   DOI   ScienceOn
12 Tokushige N, Markham R, Russell P, Fraser IS: High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Hum Reprod 21 : 782-787, 2006.
13 Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M: Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 147(1) : 71-79, 2002.   DOI   ScienceOn
14 Vaitukaitis JL: Polycystic-ovary syndrome-what is it? N Engl J Med 309 : 1245-1246, 1983.   DOI   ScienceOn
15 Lara HE, McDonald JK, Ojeda SR: Involvement of nerve growth factor in female sexual development. Endocrinology 126 : 364-375, 1990.   DOI   ScienceOn
16 Li HJ, Wang LY, Qu HN, Yu LH, Burnstock G, Ni X, Xu M, Ma B: P2Y(2) receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells. Mol Cell Endocrinol 338(1-2) : 28-37, 2011.
17 Pak SC, Kim SE, Oh DM, Shim KM, Jeong MJ, Lim SC, Nah SY, Park SH, Kang SS, Moon CJ, Kim JC, Kim SH, Bae CS: Effect of Korean red ginseng extract in a steroid-induced polycystic ovary murine model. Arch Pharm Res 32(3) : 347-352, 2009.   DOI
18 Shirwalkar H, Modi DN, Maitra A: Exposure of adult rats to estradiol valerate induces ovarian cyst with early senescence of follicles. Mol Cell Endocrinol 272(1-2) : 22-37, 2007.   DOI   ScienceOn
19 Proto MC, Gazzerro P, Di Croce L, Santoro A, Malfitano AM, Pisanti S, Laezza C, Bifulco M: Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. J Cell Physiol doi: 10.1002/jcp.22727, 2011.
20 Seidel MF, Herguijuela M, Forkert R, Otten U: Nerve growth factor in rheumatic diseases. Semin Arthritis Rheum 40(2) : 109-126, 2010.   DOI   ScienceOn
21 Snider WD: Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77(5) : 627-638, 1994.   DOI   ScienceOn
22 Sofroniew MV, Howe CL, Mobley WC: Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24 : 1217-1281, 2001.   DOI   ScienceOn
23 Do Y, Ryu S, Nagarkatti M, Nagarkatti PS: Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo. Toxicol Sci 70(1) : 63-72, 2002.   DOI
24 Lara HE, Dissen GA, Leyton V, Paredes A, Fuenzalida H, Fiedler JL, Ojeda SR: An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. Endocrinology 141 : 1059-1072, 2000.   DOI   ScienceOn
25 Doren M: Basic principles of hormone replacement therapy in the postmenopause. Ther Umsch 57(10) : 628-634, 2000.   DOI   ScienceOn
26 Ferin M, Jewelewicz R, Warren M: Menstruacni cyklus. Grada Publishing, Praha, pp. 80-83, 1997.
27 Franks S: Polycystic ovary syndrome. N Engl J Med 333 : 853-861, 1995.   DOI   ScienceOn
28 Lara HE, Ferruz JL, Luza S, Bustamante DA, Borges Y, Ojeda SR: Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology 133(6) : 2690-2695, 1993.   DOI   ScienceOn
29 Creasy GW, Kafrissen ME, Upmalis D: Review of the endometrial effects of estrogens and progestins. Obstet Gynecol Surv 47(9) : 654-678, 1992.   DOI   ScienceOn
30 Dissen GA, Garcia-Rudaz C, Paredes A, Mayer C, Mayerhofer A, Ojeda SR: Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans. Endocrinology 150(6) : 2906-2914, 2009.   DOI   ScienceOn
31 Dissen GA, Hill DF, Costa ME, Dees WL, Lara HE, Ojeda SR: A role for trkA nerve growth factor receptors in mammalian ovulation. Endocrinology 137 : 198-209, 1996.   DOI   ScienceOn
32 Dissen GA, Lara HE, Leyton V, Paredes A, Hill DF, Costa ME, Martinez-Serrano A, Ojeda SR: Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat. Endocrinology 141(3) : 1073-1082, 2000.   DOI   ScienceOn